Introduction
Development of male contraception methods is required to overcome population growth, especially in countries with high population growth. One of the strategies to develop male contraception is to create an agent that could block human sperm motility. Transmembrane proteins and ion channels are also thought to play an important role in sperm motility [1, 2] . To maintain their motility, sperm undergo a process of regulatory volume decrease wherein ions and organic osmolytes are fluxed from or into the sperm [3] . Many ion channels in sperm have been proposed as regulating sperm activity and motility [4] . Voltage-dependent anion channels (VDACs) which are found in plasma membrane and abundant in outer mitochondrial membrane are a channel protein for Na Objective: To express recombinant protein that comprises an important fragment of human sperm specific voltage dependent anion channel 3 (VDAC3) protein as a potential molecule for generation of antibody, which can affect sperm function, aiming at spermicide development.
Methods: The produce of VDAC3 recombinant protein encoded by cDNA sequence of human VDAC3 exon 5-8, based on experimental design of VDAC3 knock-out mice study. And after the purification of various human sperm VDAC3 recombinant proteins, epitope has been predicted in our recombinant protein determined by ElliPro program. Polyclonal antibody was produced for 14 wk. Then anti-VDAC3-exon 5-8 recombinant antiserum was inoculated to human sperm. After the process, antibody VDAC3 protein in human sperm was incubation with anti-VDAC3 recombinant antibody. Finally evaluation the effect of VDAC3 antiserum to human sperm motility and plasma membrane integrity was proceeded. Results: Human VDAC3 recombinant protein was successfully over-expressed in Escherichia coli and purified by affinity chromatography method. Purified human sperm VDAC3 recombinant protein could stimulate immune response in rabbit producing an antibody against VDAC3. Anti-VDAC3 recombinant antibody recognized VDAC3 antigen in human sperm could decrease human sperm motility and membrane integrity significantly. Conclusions: Anti-VDAC3 recombinant polyclonal antibody that we produced in rabbit by ourselves could decrease sperm motility and sperm membrane integrity. The authors suggest this polyclonal antibody could be used as a candidate agent for male contraception in the future. Furthermore, the authors intend to explore the effect of this antibody into sperm function aiming at male contraceptive vaccine development. ATP, succinate and malate [5] . Localization of VDACs in sperm has been reported [6, 7] . Study for the examination of regulation of
VDACs to human sperm function in capacitation suggested that
VDACs are a key factor of male fertility [8] . It has been known that male mice containing deletion of the last four exons of VDAC3 gene were infertile and showed decrease in sperm motility in comparison with wild-type male mice [9] . Various mutations in human VDAC3
gene, especially in exon 5-8 occur in infertile asthenozoospermic patients [10, 11] .
Based on previous studies it has been suggested that VDAC3 protein could be used for development of male immunocontraception.
Obtaining high amount of VDAC3 protein by genetic engineering would be an important step in applying a strategy for development of male contraception. Here, we present methods to express and purify recombinant protein that comprise an important fragment of human sperm specific VDAC3 protein as a potential molecule for generation of antibody, which can affect sperm function aimed to spermicide development.
Materials and methods

Sperm collection and production of insert fragment of human sperm VDAC3 (hVDAC3) gene
Human normozoospermic sperm was collected using a 45% and 90% discontinuous percoll (Pharmacia, Uppsala, Sweden) gradient centrifugation [12] in Cremer medium. 
Cloning of human sperm VDAC3 gene to pET 100/ D-TOPO vector
The fragment of human sperm hVDAC3 ex5-8 gene was inserted to pET 100/D-TOPO vector ( Figure 1 ) and was transformed into
Escherichia coli (E. coli) TOP 10 competent cells using TOPO directional cloning system. Transformation reactions were performed according to the Invitrogen protocol (Invitrogen, Carlsbad USA).
Positive transformed E. coli was identified and selected on Luria
Bertani medium that contains ampicillin with the final concentration of 100 μg/mL and was subsequently purified by the alkaline lyses method using Genejet Plasmid Purification Kit (Fermentas, Vilnius Lithuania). The insertion of the VDAC3 target sequence was confirmed by restriction enzyme using Hind Ⅲ as well as by PCR colony method. 
Expression and purification of human sperm VDAC3 recombinant protein
Recombinant vector pET 100/D-TOPO -hVDAC3-ex5-8
was transformed into E. coli strain BL21 Star TM (Invitrogen). 
Production of VDAC3 polyclonal antibody
The time period for producing polyclonal antibody was 14 wk.
Immunizations of rabbit with hVDAC3-ex5-8 recombinant proteins were determined sperm with good sperm membrane integrity [13] .
Uncoiled sperm defined as poor sperm membrane integrity were calculated in 200 sperm. The study was approved by the local ethics committee and informs consent was obtained from donors.
Statistical analysis
The effect of anti-VDAC3 recombinant antiserum on human sperm motility and membrane integrity compared to preimmunserum was analyzed statistically using SPSS program version 22.0 for Windows.
Data of non-motile sperm with poor membrane integrity were analyzed by t-test paired, and significance was considered at P<0.05.
Results
Production of human sperm VDAC3 insert fragment
Total RNA concentration of human sperm was 3.1 ng/μL.
Amplification of cDNA using primers covered hVDAC3-ex5-8 
Expression, purification of VDAC3 recombinant protein and generation of anti-VDAC3 antiserum
Total protein concentration in E. coli strain BL21 Star TM (DE3) that was measured after induction of IPTG in various concentrations (0 to 1 mM). The IPTG optimal concentration for the expression of protein in E. coli was 0.5 mM (P<0.05) ( Table 1) . The recombinant hVDAC3-ex5-8 fusion protein with a His-tag at N-terminus was expressed in the E. coli BL21 Star as indicated by a clear band with a molecular weight of about 22 kDa ( Figure   3A ). Using Ni-NTA agarose column hVDAC3-ex5-8 recombinant protein was purified and diluted in the buffer of purification system.
Expression of hVDAC3-ex5-8 was quantified by IMAGE J tool in the amount of 7.06% of total proteins before purification ( Figure   3B ). The presence of protein was detected at first and second elution and continuously decreased at the next elution. The protein was
finally not detected at the fifth elution ( Figure 3B ). The expression level of purified VDAC3 recombinant proteins in different of elution was presented in Figure 3C .
The prediction of tertiary dimension of hVDAC3-ex5-8 recombinant protein structure and its continuity and discontinuity is depicted in Figure 4 . A hVDAC3-ex5-8 protein structure composed of coil and 12 毬 -strand/sheet shape. The protein contains five continuous epitopes and four discontinuous epitopes for B-lymphocytes. A: Using anti-His tag antibody, the expression of protein in the size of 22 kDa was detected in line 2 and 3 respectively; while line 1 constitutes a negative control. B: Purification of hVDAC3-ex5-8 proteins: line 1 total protein before purification; line 2, 3 and 4 are protein expression after purification respectively from 1st, 2nd and 5th elution. C: Concentration of purified VDAC3 recombinant protein (μg/mL) in 1st to 5th elutions was determined. Spectrophotometric ELISA showed that hVDAC3-ex5-8 proteins can induce an immune response in immunized rabbit, which is characterized by an increase in the absorbance value of the polyclonal antibody titers at 6th, 9th and 12th week. The profile of absorbent value of VDAC3 antiserum as well as pre-immunserum is depicted in Figure 5 . 
Discussion
In the present study, we evaluated the effect of polyclonal antibody against VDAC3-ex5-8 recombinant proteins that were produced by ourselves through genetic engineering method to sperm motility and sperm membrane integrity. We have produced VDAC3 recombinant protein that encoded by cDNA sequence of hVDAC3-ex5-8, based on experimental design of VDAC3 knock-out mice study conducted by Sampson et al [9] . They deleted the 4 last exons of mouse VDAC3 gene, i.e. exon 5-8, and demonstrated there was significantly reducing of sperm motility in homozygote mutant male mice [9] .
Furthermore, mutation analysis of human VDAC3 gene in exon 5-8
showed there were various mutations in analyzed exons [10, 11] . These findings suggested exon 5-8 of VDAC3 gene are important region for the activity of protein, because a part of this region in the channel structure located in extracellular [14] , and might have proper antigenic determinants (epitope). Various epitopes have been predicted in our recombinant proteins. The ability of our recombinant protein to induce immune response generating antibody in rabbit was proven by high concentration of VDAC3 antibody. This polyclonal antibody could recognize VDAC3 protein mainly in principal piece of human sperm tail had confirmed the result study before that reported the localization of VDACs in human sperm [7] . We showed that this antibody recognize VDAC3 protein in human sperm and after 1-hour incubation with anti-VDAC3 recombinant antibody, human sperm motility decreased significantly and this antibody could increase sperm with poor membrane integrity, compared to the preimmunserum treatment. Liu et al [15] demonstrated that commercial anti-VDAC antibody that can react to three isoforms of VDAC and could decrease significantly three motility parameter of sperm, i.e.
straight line velocity, curvilinear velocity as well as average path velocity; but not significantly decrease total sperm motility [15] . Our data suggested that self-generated antibody was more specific to bind VDAC3 isoform protein in sperm, which could make defect sperm plasma membrane integrity, block channel activity and finally might
give impact to ion flux as well as ATP intake for sperm motility. [16, 17] . VDACs are abundant proteins found in outer mitochondrial membrane and their channels allow diffusion of small hydrophilic solutes through the membrane [18, 19] . Several studies reported that VDACs are found also in plasma membrane [20, 21] . Phosphorylated VDAC1 isoform in plasmalemmal work together with channel modulator can regulate cell volume and extracellular apoptotic pathway [22] . Our study using self-generated anti-VDAC3 recombinant antibody indicated that the presence of VDAC3 in human sperm flagellum suggested the location of this channel was also in sperm tail membrane. Sperm mitochondria located only in midpiece region of sperm tail producing energy source to drive the tail. VDAC3 in sperm membrane might facilitate flux of ions required to initiate and support sperm motility.
Sperm with rapid and progressive movement is required to penetrate an egg at fertilization. Incubation of sperm with anti-sperm protein antibody that can lower sperm movement is a promising method for development of contraceptive agent such as spermicide.
Anti-VDAC3 recombinant polyclonal antibody that we produced in rabbit by self could decrease sperm motility and sperm membrane integrity. We suggest this polyclonal antibody could be used as a candidate agent for male contraception in the future. Furthermore, we intend to explore the effect of this antibody into sperm function aiming at male contraceptive vaccine development.
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